Open Markets submitted a letter to the French Competition Authority advocating for updates to France's merger control thresholds to address concerns over "killer acquisitions" by dominant firms, especially in Big Tech and Big Pharma, emphasizing the need for a more robust and flexible regulatory framework.
Read More